Navigation Links
Sinovac Reports Unaudited Third Quarter 2009 Financial Results
Date:11/15/2009

1,443,834 811,901 2,753,009 2,408,745 $133,176 (2008- $16,829) for three months and $261,861 (2008- $147,958) for nine months in government research grants Depreciation of property, plant and equipment and amortization of licenses and permits 179,962 178,404 511,835 526,117 Total operating expenses 5,143,773 4,782,221 15,192,723 16,343,314 Operating income 12,405,217 2,312,588 23,730,137 12,473,120 Interest and financing expenses (246,036) (189,935) (571,349) (747,496) Interest income and other income (expenses) 77,300 58,456 243,451 (36,685) Income before income taxes and non-controlling interest 12,236,481 2,181,109 23,402,239 11,688,939 Income taxes recovery (expense) - Current (3,230,985) (1,005,174) (5,026,902) (4,229,613) - Deferred (551,478) 94,028 (1,399,428) 991,461 Consolidated net income for the period 8,454,018 1,269,963 16,975,909 8,450,787 Less: net income attributable to non-controlling interest (3,228,659) (530,084) (5,917,215) (2,814,703) Net income attributable to the stockholders $5,225,359 $739,879 $11,058,694 $5,636,084 Net income for the period $8,454,018 1,269,963 16,975,909 8,450,787 Other comprehensive income Foreign currency translation adjustment 64,108 33,637 90,728 2,358,956 Total comprehensive income 8,518,126 1,303,600 17,066,637 10,809,743 Less: comprehensive income attributable to non-controlling interest 3,229,599 522,960 5,9
'/>"/>
SOURCE Sinovac Biotech Co., Ltd.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related biology technology :

1. Sinovac Obtains Third H1N1 Vaccine Order from Chinese Central Government
2. Sinovac Receives Certificate of Approval to Distribute Panflu (H5N1) Vaccine in Hong Kong
3. Sinovac to Present at 2009 UBS Global Life Sciences Conference
4. Sinovac Obtains Lot Release Certificate for Its First Batch of H1N1 Vaccine
5. Sinovac Obtains Initial Order of H1N1 Vaccine from Chinese Central Government
6. Sinovac Obtains Production License for H1N1 Vaccine
7. Sinovac to Host Conference Call to Report 2009 Second Quarter Financial Results
8. Revised: Sinovac Provides Update on Clinical Trial for H1N1 Vaccine Trials
9. Sinovac Provides Update on Clinical Trial for H1N1 Vaccine Trials
10. Sinovac Initiates Dosing in Human Clinical Trial of Panflu for Pandemic Influenza A (H1N1)
11. Sinovac Adjourns 2008 Annual General Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... 22 de enero de 2015  El Dr. Paul ... llamada a nominaciones para 2015. Este prestigioso premio reconoce ... tiene el potencial para hacer, contribuciones destacadas para la ... hasta el 15 de marzo de 2015 a través ...
(Date:1/22/2015)... PALO ALTO, Calif. , Jan. 22. 2015  Varian Medical ... equipment and software, has been honored for its commitment to ... most sustainable companies. Varian is the highest ranked healthcare equipment ... ranking, announced today during the World Economic Forum at ...
(Date:1/22/2015)... , Jan. 22, 2015  Derma Sciences, Inc. (Nasdaq: ... focused on advanced wound care, announces that AMNIOEXCEL® ... have been added to the Premier, Inc. Regenerative ... opportunity for the AMNIOEXCEL® and AMNIOMATRIX® product lines, ...
(Date:12/24/2014)... Md. , Dec. 24, 2014  United Therapeutics Corporation ... Inc. (NYSE: MDT ) has submitted a ... Administration (FDA) for the use of Medtronic,s SynchroMed ® ... developed catheter) for use with United Therapeutics, Remodulin ® ...
Breaking Biology Technology:El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 2El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 3El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 4Varian Honored Among World's 100 Most Sustainable Corporations 2Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 2Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 3Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 4Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 5United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 3United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 4
... Calif., Feb. 17 Frost & Sullivan, the,Growth Partnership ... strength, thanks in part to an unprecedented US $1 ... packages from,foreign governments. , (Logo: ... "President Obama,s stimulus package is clearly serving to convince,businesses ...
... researchers at the University of Warwick have found that ... to the interface of two non mixing liquids ... new possibilities for the uses of nanoparticles in living ... paints. The researchers are also working on ways of ...
... and HANGZHOU, China, Feb. 17 Dow,AgroSciences LLC, a ... DOW ), and the China National Rice Research ... entered into a research agreement to,combine the strengths of ... rice germplasm. , "We look ...
Cached Biology Technology:Frost & Sullivan Forecasts Early Rebound: Strong Growth Ahead for Global Economy 2Nanoparticles double their chances of getting into sticky situations 2Dow AgroSciences, China National Rice Research Institute Announce Collaboration on Rice Research 2
(Date:12/22/2014)... Dec. 22, 2014  The 2014 Holiday Season may be ... Market Intelligence reports that the long anticipated floodgates for ... intensifying demand for smart phones, tablets, and wearable mobile ... of 2.5 billion users with nearly 4.8 billion biometric ...
(Date:12/19/2014)... , Dec. 18, 2014   LaunchKey , the ... the post-password and Internet of Things era, today announced ... The venture round was led by Metamorphic Ventures with ... Venture Partners, VegasTechFund, and others.  LaunchKey has raised $4 ...
(Date:12/17/2014)... 2014 Valencell, a leader in performance biometric data ... industry leaders such as Intel, Jabra, Atlas, and Scosche ... products. These products will be showcased at CES 2015, ... . "Our partners choose PerformTek ...
Breaking Biology News(10 mins):First Season of Holiday Shopping with Mobile Biometric Payments Wraps Up With a Present for Biometrics Industry: A Rosy Forecast for More Than 2 Billion Users of 4.8 Billion Mobile Biometric Devices by 2020 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 3Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2
... INDIANAPOLIS Indiana University researchers have introduced Laboratree, ... scientific collaboration. Designed to streamline research and ... Laboratree will enable scientists to securely manage research ... group messages, author blogs, and customize personal and ...
... in the wrong place to protect vulnerable coral reefs from ... warned today., Now the team led jointly by Newcastle ... that urgent action is needed to prevent the collapse of ... the journal PLoS ONE , is the largest study ...
... It,s no secret that humans are having a huge impact ... Barbara,s Steven D. Gaines and fellow researcher Dov Sax decided ... Their research, published this month in the Proceedings ... on the subject of extinction rates of species on islands. ...
Cached Biology News:Indiana U researchers launch social networking and research management tool for scientists 2No-take zones offer no boost for bleached reefs 2Study of islands reveals surprising extinction results 2Study of islands reveals surprising extinction results 3
... 8-iso-13,14-dihydro-15-keto Prostaglandin F2α (8-iso-13,14-dihydro-15-keto PGF2α) ... 8-isoprostane (8-iso PGF2α), in rabbits, monkeys ... PG-like product of non-specific lipid peroxidation. ... infused 8-isoprostane is converted primarily to ...
kismet (dK-20)...
...
Porcine Pulmonary Artery Endothelial Cells (PPAEC) (>500,000 cells)...
Biology Products: